Nociceptive brain activity as a measure of analgesic efficacy in infants
- 3 May 2017
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 9 (388)
Abstract
A measure of nociceptive brain activity that can be used to assess analgesic efficacy in infants is derived and validated.Keywords
Funding Information
- Wellcome Trust (award283655)
This publication has 46 references indexed in Scilit:
- Neonatal Pain in Very Preterm Infants: Long-Term Effects on Brain, Neurodevelopment and Pain ReactivityRambam Maimonides Medical Journal, 2013
- Multi-modal pain measurements in infantsJournal of Neuroscience Methods, 2012
- A Shift in Sensory Processing that Enables the Developing Human Brain to Discriminate Touch from PainCurrent Biology, 2011
- Oral sucrose as an analgesic drug for procedural pain in newborn infants: a randomised controlled trialThe Lancet, 2010
- Latency to facial expression change following noxious stimulation in infants is dependent on postmenstrual agePain, 2009
- How Well Do Clinical Pain Assessment Tools Reflect Pain in Infants?PLOS Medicine, 2008
- Topical amethocaine gel 4% for intramuscular injection in term neonates: A double-blind, placebo-controlled, randomized trialClinical Therapeutics, 2008
- The Cerebral Signature for Pain Perception and Its ModulationNeuron, 2007
- A Critical Review of the Topical Local Anesthetic Amethocaine (Ametop???) for Pediatric PainPediatric Drugs, 2005
- Does a local anaesthetic cream (EMLA) alleviate pain from heel‐lancing in neonates?Acta Anaesthesiologica Scandinavica, 1995